What Happens If You Take Too Many Anxiety Pills?

Taking too many anxiety pills can cause effects ranging from heavy sedation and confusion to life-threatening drops in heart rate, breathing failure, or a dangerous buildup of brain chemicals, depending on which medication is involved and how much was taken. The answer is not one-size-fits-all because “anxiety pills” span several unrelated drug classes, each with its own overdose profile. A benzodiazepine overdose looks very different from an SSRI overdose or a beta-blocker overdose, and the danger rises sharply when more than one substance is in the mix.

Benzodiazepine Overdose

Benzodiazepines like alprazolam (Xanax), diazepam (Valium), and lorazepam (Ativan) are among the most commonly prescribed anxiety medications and also among the most commonly involved in overdose cases. An emergency-department study found that diazepam and alprazolam appeared over-represented in overdose data relative to how often they were prescribed in the general population.¹

When someone takes too many benzodiazepines on their own, the typical result is mild to moderate sedation. The person may become very drowsy, confused, slur their speech, and lose coordination. Deep coma requiring a ventilator is uncommon in pure benzodiazepine overdoses, and deaths from benzodiazepines alone are rare.² That sounds reassuring, but it comes with a critical caveat: the moment alcohol, opioids, or other sedating drugs are involved, the danger multiplies. The severity also depends on the dose, the person’s age, and any pre-existing health conditions.

In severe cases, benzodiazepines can occasionally cause cardiovascular problems and suppressed breathing. If someone loses consciousness and stays in one position for hours, the pressure on muscles can trigger a condition called rhabdomyolysis, where compressed muscle tissue breaks down and releases proteins that damage the kidneys.³ One case report described a woman who developed rhabdomyolysis and kidney impairment after overdosing on nitrazepam and another drug; her kidney markers spiked dramatically within two days, and movement in her legs became restricted.⁴ This secondary damage from prolonged unconsciousness is an underappreciated risk of any overdose that knocks a person out for an extended period.

SSRI and SNRI Overdose

Selective serotonin reuptake inhibitors (SSRIs) like sertraline, fluoxetine, and paroxetine are now first-line treatments for many anxiety disorders. They are generally safer in overdose than benzodiazepines in terms of sedation and breathing, but they carry their own distinctive danger: serotonin syndrome. This is a condition caused by too much serotonin activity in the brain, and it can be triggered by an overdose of a single serotonergic medication or by combining multiple ones.

Serotonin syndrome looks nothing like the sleepy sedation of a benzodiazepine overdose. Symptoms typically include agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, tremors, sweating, and diarrhea.⁵ In severe cases, complications can escalate to rhabdomyolysis, seizures, multi-organ dysfunction, and death. The risk increases when SSRIs and SNRIs are combined, even if there has been only a short interval between taking the two types.⁶

A case report illustrates how extreme this can get: a 25-year-old woman attempted suicide by ingesting 60 tablets of fluvoxamine, 20 tablets of sertraline, and 10 tablets of paroxetine simultaneously, all SSRIs.⁷ Serotonin syndrome ranges in severity from mild tremors and restlessness that might be mistaken for anxiety itself, all the way to a medical emergency requiring intensive care. The fact that milder cases can be overlooked is part of what makes this condition dangerous.

Beta-Blockers and Other Anxiety Medications

Propranolol and other beta-blockers are sometimes prescribed for the physical symptoms of anxiety, particularly performance anxiety and panic attacks. They work by slowing the heart and reducing the effects of adrenaline. In overdose, that heart-slowing effect becomes the core problem. A large prospective study of propranolol overdose found that about one in five patients developed a dangerously slow heart rate, and roughly two in five developed low blood pressure. About a quarter experienced severe toxicity, including seizures in 8% and coma in 14%. Seven patients went into cardiac arrest, and two died, after ingesting between 4,000 and 16,000 milligrams.⁸ In people who took only propranolol without other drugs, severe toxicity started appearing at doses of about 2,000 milligrams, and more than half of those who took that much or more became seriously ill.

Hydroxyzine (brand name Vistaril) is an antihistamine sometimes prescribed for anxiety. Its overdose profile is milder than most other anxiety drugs. A large cohort analysis found that hydroxyzine-poisoned patients had lower rates of coma, respiratory depression, seizures, and dangerous heart rhythms compared to patients who had overdosed on a related antihistamine. Death from hydroxyzine poisoning was extremely rare, occurring in fewer than 1% of cases in both datasets studied.⁹ That said, mild central nervous system depression, essentially heavy drowsiness, was actually more common with hydroxyzine than with the comparison drug.

Pregabalin (Lyrica), a gabapentinoid prescribed for generalized anxiety disorder in some countries, presents a relatively mild overdose picture when taken alone. On its own, a pregabalin overdose typically causes mild sedation and, uncommonly, seizures. But when sedating drugs are also involved, coma becomes common.¹⁰ This pattern, relatively manageable when the drug is alone but far more dangerous with co-ingestants, repeats across nearly every class of anxiety medication.

Why Mixing Substances Changes Everything

The single most important factor in whether an anxiety-pill overdose becomes fatal is whether other substances are present. A pure benzodiazepine overdose is rarely lethal; add alcohol or an opioid, and the risk of death climbs steeply. A deep coma from benzodiazepines should prompt clinicians to search for other toxic substances, because benzodiazepines alone rarely produce that level of sedation.²

Research on young adults found that those prescribed benzodiazepines had a roughly 36% to 59% higher rate of medically treated drug overdose compared to those prescribed SSRIs alone, depending on insurance type. When both a benzodiazepine and an SSRI were prescribed together, the overdose rate approximately doubled compared to an SSRI alone.¹¹ These numbers reflect real-world overdoses in people who filled prescriptions, not just theoretical risk.

Hypnotic drugs, including some benzodiazepines and related sleep aids, carry their own overdose concerns. Research has linked them to excess mortality from overdose deaths, quiet deaths at night, and suicides, with even short-term use of one or two prescriptions carrying greater risk per dose than long-term use. Other risks include automobile crashes, falls, and other accidents caused by residual sedation.

What Happens in the Emergency Room

Emergency treatment for an anxiety-pill overdose depends on what was taken and how long ago. One of the first interventions, when timing allows, is activated charcoal. This works by binding to the drug in the stomach and intestines before it gets absorbed into the bloodstream. The evidence supports giving activated charcoal as soon as possible, ideally within the first hour after ingestion.¹² Research has found that charcoal given after the one-hour window does not reliably improve outcomes, though extended-release medications may allow a longer window of up to six hours.¹³

For benzodiazepine overdoses specifically, there is a reversal agent called flumazenil that blocks the drug’s effects at the receptor. In a ten-year poison center study, more than half of patients who received flumazenil became alert afterward.¹⁴ However, flumazenil is not handed out freely. It can trigger seizures, especially in people who also took a drug that lowers the seizure threshold. In that same study, seizures occurred in about 1.4% of cases, and the risk was more than three times higher when a pro-convulsant drug was also on board. A more recent analysis found that agitation was the most common adverse effect, occurring in about 14% of patients, while seizures affected about 2.6%, again almost exclusively in people with a pro-convulsant co-exposure.¹⁵ People who use benzodiazepines chronically are also at particular risk for adverse reactions from flumazenil, because reversing the drug suddenly can precipitate withdrawal.

For serotonin syndrome, the treatment approach is different. Supportive care is the foundation: cooling the patient, controlling agitation, and managing heart rate. Cyproheptadine, a drug that blocks serotonin receptors, is commonly recommended as an add-on treatment. In small case series, patients who received cyproheptadine had resolution of symptoms within two hours, though some needed repeat doses for residual tremor or hyperreflexia.¹⁶ For severe cases requiring intensive care, the recommended protocol involves a loading dose of 12 milligrams followed by 2 milligrams every two hours until symptoms improve, then a maintenance dose.¹⁷ That said, a systematic review concluded that there is still a lack of solid evidence that cyproheptadine truly changes outcomes, and its use remains considered an adjunct to supportive care rather than a cure.¹⁸

Older Adults and Children Face Greater Risks

Age changes the equation in both directions. Older adults metabolize many anxiety medications more slowly because kidney and liver function decline with age. Fat-soluble drugs like most benzodiazepines also get stored in body fat and released more gradually, prolonging their effects. A review of aging and pharmacology found that decreased kidney and liver clearance, combined with an increased volume of distribution for fat-soluble drugs, extends elimination time.¹⁹ In practical terms, a dose that would produce moderate sedation in a healthy 30-year-old can cause prolonged coma or dangerous drops in blood pressure in an 80-year-old. The long-term risks of benzodiazepine use in older adults also extend beyond overdose to include cognitive decline and fall-related injuries.

Children are vulnerable in a different way. Their lower body weight means that even a small number of pills can produce a massive effective dose. A case report described a child who accidentally ingested sertraline and developed prolonged rapid heart rate, high blood pressure, hallucinations, coma, high body temperature, and tremors in all limbs.²⁰ This constellation of symptoms, serotonin syndrome in a pediatric patient, underscores why safe storage of psychiatric medications matters as much as dosing accuracy. A toddler getting into a parent’s anxiety medication is a genuine emergency-room scenario that poison control centers handle regularly.

The Difference Between Dependence and Overdose

People sometimes conflate two separate problems: physical dependence on anxiety medication and overdose. They are not the same, though they can interact. Regular use of benzodiazepines causes physical and psychological dependence, and the withdrawal symptoms can resemble alcohol withdrawal, sometimes dangerously so. Stopping suddenly after long-term use can itself be life-threatening, with risks including seizures.

This matters for overdose in a subtle way. Someone who has been taking benzodiazepines daily for months develops tolerance, meaning their usual dose produces less effect. That tolerance might lead them to take more, increasing overdose risk. And if an overdose is treated with flumazenil (the reversal agent), the sudden removal of the drug’s effect can throw a dependent person straight into acute withdrawal, potentially triggering seizures on top of the overdose situation. Chronic benzodiazepine users who received flumazenil were disproportionately represented among those who had adverse events in a recent retrospective analysis.¹⁵

Recovery Is Not Always Instant

Surviving an anxiety-pill overdose is not the end of the story. Even after the acute danger has passed and the drug has been cleared from the body, the brain can take weeks to fully normalize. A study tracking patients after drug overdose found that abnormal sleep patterns persisted for up to two months after the event, resolving only gradually.²¹ Patients recovering from prolonged coma may also deal with the physical aftermath of muscle breakdown and kidney stress described earlier, sometimes requiring dialysis or rehabilitation.

There is also a cognitive and emotional dimension. People who overdose on benzodiazepines sometimes report days of foggy thinking afterward. Those who experienced serotonin syndrome may feel physically drained for weeks, with muscle soreness and fatigue lingering. And the psychological aftermath, whether the overdose was intentional or accidental, often requires its own care. Emergency departments increasingly screen overdose patients for mental health needs before discharge, because a substantial portion of medication overdoses involve intentional self-harm.

When Drug Tests Get It Wrong

An interesting footnote for anyone who has been through an overdose evaluation or who takes anxiety medications and undergoes drug screening: standard urine drug tests for benzodiazepines are not as reliable as most people assume. Most screening assays detect benzodiazepines by looking for specific metabolites, mainly nordiazepam and oxazepam. Several commonly prescribed benzodiazepines, including alprazolam, clonazepam, lorazepam, and triazolam, follow different metabolic pathways and frequently produce false-negative results.²² In other words, someone who overdosed on alprazolam could test negative for benzodiazepines on a standard screen.

The false-positive side is equally messy. A retrospective chart analysis found that sertraline, a common SSRI prescribed for anxiety, was associated with false-positive benzodiazepine results on a widely used screening test. Out of 160 false-positive benzodiazepine results, 26 were linked to patients taking sertraline.²³ This can complicate emergency treatment, where knowing exactly what someone took determines which interventions are safe. It can also affect patients in pain-management programs or other monitored settings, where a false positive for benzodiazepines might trigger consequences unrelated to what the person actually ingested.